ArcheMedX

ArcheMedX is a life sciences software company that develops the Ready platform, a training and readiness assessment solution designed to help CROs, pharmaceutical sponsors, biotechs, and healthcare organizations prepare clinical teams and clinicians for study execution. The platform focuses on equipping, evaluating, and predicting the performance of trial site staff, commercial teams, and clinicians through behavioral science-informed approaches to training and readiness measurement.

Ready has powered more than 1,000,000 user sessions with clinical professionals from over 90 countries, and its predictive engine has modeled over 70 million behavioral data points. Twenty-one of the top 25 pharmaceutical firms, as well as emerging biotechs and leading healthcare organizations, have used the platform.

Core Use Cases

• Clinical Operations: Supports CROs and trial sponsors in optimizing trial delivery by tailoring training by role, identifying site and team risks earlier in the study lifecycle, accelerating site activation and enrollment, and reducing overall study team burden and costs.
• Commercial Team Readiness: Helps commercial teams and clinicians build capabilities to accelerate product adoption, and validates which individuals are ready to change behavior in the field or in clinical practice.
• Medical Education: Delivers clinical education tailored to specific learning objectives and clinical outcomes, with the goal of improving clinical care and accelerating practice change among clinicians.

Platform Capabilities

• Confidence-Based Assessment (CBA) methodology to identify gaps in clinician and team readiness that traditional training approaches may not detect.
• A predictive readiness measure engineered from behavioral data, described as the first of its kind, intended to inform operational decisions before problems appear in study data.
• Role-based training tailoring to address the most critical areas of a given study.
• Site initiation support tools aimed at streamlining startup processes and reducing associated study budgets.
• Application of behavioral science concepts including nudge theory, fast and slow thinking, and choice architectures to address operational challenges in clinical trials.

Research and Data Highlights

• ArcheMedX presented findings from the largest known Confidence-Based Assessment dataset in CNS at the CNS Summit, drawn from over 5 million question responses generated by more than 400,000 CNS-treating clinicians on the Ready platform.
• The findings highlighted significant gaps in clinician readiness that conventional training methods fail to detect.
• The company has published content and hosted webinars exploring how behavioral science can address enrollment challenges, noting that over 80% of clinical trials face enrollment difficulties.
• ArcheMedX leadership has presented at industry events including the SCOPE Summit and the Precision in Clinical Trials Summit, covering topics such as site initiation efficiency and early risk identification.

Company Details

• Headquartered at 300 E Main Street, Suite 101, Charlottesville, VA 22902.
• Led by CEO and Co-Founder Joel Selzer, with research contributions from Brian S. McGowan, PhD.
• Serves both clinical operations and medical education segments within the life sciences and healthcare industries.

ArcheMedX positions Ready as a tool for reducing trial delays, risks, and costs by measuring and predicting readiness at the point of training and site initiation, rather than after operational problems have already emerged in study data.